Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
17 Jul 2026 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences Researcher Profile Established Researcher (R3) Leading
-
17 Jul 2026 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences Researcher Profile Established Researcher (R3) Leading
-
also investigate the contribution of placodal cells, including non-neuronal mantle cells, to skin remodelling and orifice opening. The project combines developmental and molecular biology, single-cell
-
11 Sep 2026 Job Information Organisation/Company INSERM Department Signaling and Pathogenesis Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Positions
-
(BPV), INSERM U1347, Institut Pasteur led by Chetan Chitnis for an ANR-funded malaria drug development project in collaboration with INSERM U1177, Université de Lille and Institut Pasteur de Lille
-
French National Institute for Health Research (INSERM) | Paris 15, le de France | France | about 2 months ago
The INSERM Chair “Regulation of the Immune System” aims to identify new mechanisms regulating the immune system by considering the global context of the host and the tissues in which immune cells
-
17 Jul 2026 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences Researcher Profile Established Researcher (R3) Leading
-
17 Jul 2026 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences Researcher Profile Established Researcher (R3) Leading
-
17 Jul 2026 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences Researcher Profile Established Researcher (R3) Leading
-
: By opening an Inserm chair, the INCIT Laboratory aims to recruit an emerging leader developing innovative approaches in adoptive T cell-based immunotherapy. The selected candidate will bring strong